Fatal heart disease in patients with bone and soft tissue sarcoma
Background/purposeWith improved cancer survivorship, non-cancer events, especially heart disease (HD), have become the underlying cause of death in cancer patients, but the risk of HD mortality in sarcoma patients remains poorly characterized. Therefore, our purpose was to: (1) identify sarcoma pati...
| Published in: | Frontiers in Cardiovascular Medicine |
|---|---|
| Main Authors: | Bei Chen, Xin Zhao, Xiying Li, Jun Liu, Juyu Tang |
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2022-10-01
|
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fcvm.2022.951940/full |
Similar Items
A Review: Molecular Aberrations within Hippo Signaling in Bone and Soft Tissue Sarcomas
by: Michael D Deel, et al.
Published: (2015-09-01)
by: Michael D Deel, et al.
Published: (2015-09-01)
Local Tumor Control Affects Survival of Patients with Osteosarcoma and Ewing Sarcoma
by: Nur Suryawan, et al.
Published: (2025-06-01)
by: Nur Suryawan, et al.
Published: (2025-06-01)
Systemic treatment for primary malignant sarcomas arising in craniofacial bones
by: Stefan S. Bielack, et al.
Published: (2022-09-01)
by: Stefan S. Bielack, et al.
Published: (2022-09-01)
Frozen inactivated autograft replantation for bone and soft tissue sarcomas
by: Zhichao Tian, et al.
Published: (2024-02-01)
by: Zhichao Tian, et al.
Published: (2024-02-01)
Editorial: Efficacy, safety and biomarkers of novel therapeutics and regimens in the peri-operative setting of bone and soft tissue sarcoma
by: Qiyuan Bao, et al.
Published: (2023-08-01)
by: Qiyuan Bao, et al.
Published: (2023-08-01)
Targeting metastasis in paediatric bone sarcomas
by: Emma C. Bull, et al.
Published: (2025-05-01)
by: Emma C. Bull, et al.
Published: (2025-05-01)
Treatment Outcomes and Prognostic Factors of Pulmonary Metastasectomy for Bone and Soft Tissue Sarcoma: a High Volume Academic Institution Experience
by: Xiaozheng KANG, et al.
Published: (2016-05-01)
by: Xiaozheng KANG, et al.
Published: (2016-05-01)
Advances in the treatment of soft tissue sarcoma: focus on eribulin
by: Koliou P, et al.
Published: (2018-02-01)
by: Koliou P, et al.
Published: (2018-02-01)
Canine soft tissue sarcomas: the expression of RUNX2 and karyopherin alpha-2 in extraskeletal (soft tissues) and skeletal osteosarcomas
by: Leonardo Leonardi, et al.
Published: (2024-02-01)
by: Leonardo Leonardi, et al.
Published: (2024-02-01)
Biopsy Path Contamination in Primary Bone Sarcomas
by: Jairo Greco Garcia, et al.
Published: (2019-05-01)
by: Jairo Greco Garcia, et al.
Published: (2019-05-01)
Clinical outcomes of radio‐hyperthermo‐chemotherapy for soft tissue sarcoma compared to a soft tissue sarcoma registry in Japan: a retrospective matched‐pair cohort study
by: Hisaki Aiba, et al.
Published: (2018-04-01)
by: Hisaki Aiba, et al.
Published: (2018-04-01)
Multi‐Targeted Kinase Inhibitor Therapy in Pediatric Bone and Soft Tissue Sarcoma Patients—A Single Centre Experience
by: Anna Mohás, et al.
Published: (2025-05-01)
by: Anna Mohás, et al.
Published: (2025-05-01)
Exosomes in Bone Sarcomas: Key Players in Metastasis
by: Mariona Chicón-Bosch, et al.
Published: (2020-01-01)
by: Mariona Chicón-Bosch, et al.
Published: (2020-01-01)
Systemic chemotherapy of advanced soft tissue sarcomas
by: Mehmet Besiroglu, et al.
Published: (2017-07-01)
by: Mehmet Besiroglu, et al.
Published: (2017-07-01)
Pediatric bone sarcomas: Outcome of multimodality treatment in a single institution in South India over a decade
by: Subbiah Shanmugam, et al.
Published: (2019-01-01)
by: Subbiah Shanmugam, et al.
Published: (2019-01-01)
SOFT TISSUE SARCOMA: A MODERN VIEW TO THE PROBLEM
by: V.V. BENBERIN, et al.
Published: (2019-06-01)
by: V.V. BENBERIN, et al.
Published: (2019-06-01)
Efficacy and Safety of Fruquintinib‐Based Treatment in Patients with Refractory Bone and Soft Tissue Sarcoma after Developing Resistance to Several TKIs: A Multicenter Retrospective Study
by: Chenchen Yang, et al.
Published: (2024-10-01)
by: Chenchen Yang, et al.
Published: (2024-10-01)
Practical Management of Adult Ultra-Rare Primary Retroperitoneal Soft Tissue Sarcoma: A Focus on Perivascular Epithelioid Tumours and Extraosseous Ewing Sarcoma
by: Sameer S. Apte, et al.
Published: (2023-06-01)
by: Sameer S. Apte, et al.
Published: (2023-06-01)
Role of neutrophils and NETs in osteosarcoma and soft tissue sarcoma
Published: (2024-10-01)
Published: (2024-10-01)
Homogenous and Heterogenous Prognostic Factors for Patients with Bone Sarcoma
by: Guijun Xu, et al.
Published: (2021-02-01)
by: Guijun Xu, et al.
Published: (2021-02-01)
Chemotherapeutic drugs for soft tissue sarcomas: a review
by: Zhichao Tian, et al.
Published: (2023-08-01)
by: Zhichao Tian, et al.
Published: (2023-08-01)
Advanced soft-tissue sarcoma and treatment options: critical appraisal of trabectedin
by: Desar IME, et al.
Published: (2016-08-01)
by: Desar IME, et al.
Published: (2016-08-01)
Primary osteogenic sarcoma of the breast
by: Jacob Sunitha, et al.
Published: (2010-10-01)
by: Jacob Sunitha, et al.
Published: (2010-10-01)
Editorial: New therapeutics for soft tissue sarcomas
by: Marla Weetall, et al.
Published: (2023-10-01)
by: Marla Weetall, et al.
Published: (2023-10-01)
Patients with osteosarcoma and soft tissue sarcoma might become "cancer refugees" in some Japanese regional cities
by: Yamane H, et al.
Published: (2018-02-01)
by: Yamane H, et al.
Published: (2018-02-01)
Case Report: Clinical application of immunotherapy-based combination regimen in primary osteosarcoma of the uterus
by: Jing Yang, et al.
Published: (2023-07-01)
by: Jing Yang, et al.
Published: (2023-07-01)
The efficacy and safety of anlotinib combined with chemotherapy in treatment of advanced soft tissue sarcoma
by: Ying Ni, et al.
Published: (2024-10-01)
by: Ying Ni, et al.
Published: (2024-10-01)
Hyperthermia in the treatment of high-risk soft tissue sarcomas: a systematic review
by: Paraskevi Danai Veltsista, et al.
Published: (2023-12-01)
by: Paraskevi Danai Veltsista, et al.
Published: (2023-12-01)
Bone sarcoma follow-up; a nationwide analysis of oncological events after initial treatment
by: Louren M. Goedhart, et al.
Published: (2023-02-01)
by: Louren M. Goedhart, et al.
Published: (2023-02-01)
Osteosarcoma and Ewing Sarcoma of Bone: An Italian Mono-Institutional Epidemiological Study
by: Cristina Ferrari, et al.
Published: (2025-01-01)
by: Cristina Ferrari, et al.
Published: (2025-01-01)
Manual and semiautomatic segmentation of bone sarcomas on MRI have high similarity
by: F.C.F. Dionísio, et al.
Published: (2020-01-01)
by: F.C.F. Dionísio, et al.
Published: (2020-01-01)
Beyond the bones: Extraskeletal osteosarcoma of the thigh
by: Bader Abou Shaar, MBBS, et al.
Published: (2023-06-01)
by: Bader Abou Shaar, MBBS, et al.
Published: (2023-06-01)
Gemcitabine Maintenance Therapy in Patients With Metastasized Soft Tissue Sarcomas
by: Dennis Christoph Harrer, et al.
Published: (2021-12-01)
by: Dennis Christoph Harrer, et al.
Published: (2021-12-01)
CLINICAL MASKS OF BONE SARCOMAS IN CHILDREN: SIX CLINICAL CASES
by: Maxim Yu. Rykov
Published: (2018-04-01)
by: Maxim Yu. Rykov
Published: (2018-04-01)
Evaluation of the effect of neoadjuvant chemotherapy on the planned resectability of extremity soft-tissue sarcomas
by: Simon Tournemine, et al.
Published: (2025-05-01)
by: Simon Tournemine, et al.
Published: (2025-05-01)
SHH Signaling Pathway Drives Pediatric Bone Sarcoma Progression
by: Frédéric Lézot, et al.
Published: (2020-02-01)
by: Frédéric Lézot, et al.
Published: (2020-02-01)
IL-1 Family Members in Bone Sarcomas
by: Lorena Landuzzi, et al.
Published: (2024-01-01)
by: Lorena Landuzzi, et al.
Published: (2024-01-01)
Emerging trends in immunotherapy for pediatric sarcomas
by: Kyle A. Dyson, et al.
Published: (2019-07-01)
by: Kyle A. Dyson, et al.
Published: (2019-07-01)
The YAP/TAZ Pathway in Osteogenesis and Bone Sarcoma Pathogenesis
by: Heinrich Kovar, et al.
Published: (2020-04-01)
by: Heinrich Kovar, et al.
Published: (2020-04-01)
Investigation of the Incidence and Geographic Distribution of Bone and Soft Tissue Sarcomas in Canada: A National Population-Based Study
by: Badria Alkazemi, et al.
Published: (2023-06-01)
by: Badria Alkazemi, et al.
Published: (2023-06-01)
Similar Items
-
A Review: Molecular Aberrations within Hippo Signaling in Bone and Soft Tissue Sarcomas
by: Michael D Deel, et al.
Published: (2015-09-01) -
Local Tumor Control Affects Survival of Patients with Osteosarcoma and Ewing Sarcoma
by: Nur Suryawan, et al.
Published: (2025-06-01) -
Systemic treatment for primary malignant sarcomas arising in craniofacial bones
by: Stefan S. Bielack, et al.
Published: (2022-09-01) -
Frozen inactivated autograft replantation for bone and soft tissue sarcomas
by: Zhichao Tian, et al.
Published: (2024-02-01) -
Editorial: Efficacy, safety and biomarkers of novel therapeutics and regimens in the peri-operative setting of bone and soft tissue sarcoma
by: Qiyuan Bao, et al.
Published: (2023-08-01)
